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P. Tarak-Penguin Case

ble right, a right which they have never
enjoyed but that could provide an important tool for future similar situations.
When the judge reminded the claimant
that "popular" or "citizen" actions were
not part of the current legal code, many
of those in the conservation community
found this judgment unfair. Suddenly, it
become obvious that the movement had
somehow to gain that right. With standing in court, conservationists could act
more effectively as protectors of nature.
Who can say what would have happened if the conservation groups had
found out about the project too late,
and had therefore been unable to work
with the media so as to give the penguin's
plight the publicity it deserved? Would
the judge have reacted as he did if, after
all, he had not been obliged to notify the
president about the case (assuming that
there had been no sort of other political
pressure)?
To reiterate, in this case, the legal
process only served as a political toolit could not function by itself to resolve
an unjust situation.
Under Argentine law, those matters
that pertain to general concerns or the
public domain come under the protection and control of the government. Yet,
this function may not be shared with the
citizens, beyond simple denouncements
of unlawful events. Accordingly, when a
crime threatens wildlife (penguins, in
this case), only the government can take
action. However, a problem arises whenever the governmental authorities become vulnerable to a course that strays
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from its previous commitments. As aresult, wildlife may well be left to its own
fate. This is a situation that Argentines
must change.
At one point, a local Buenos Aires
magazine published a drawing of a penguin saying, "Prevent my death - I can't."
This caption drives home the point that
penguins do not have the standing in
court that may be necessary for protection of their lives. And it is unfortunate
that in Argentina, as well as in many
other Latin American countries, citizens,
too, are denied the basic right to defend
the penguins against very powerful economic interests.
It would be useful if the world conservation movement would become more
aware of this fact, and assist those countries in which conservationists still need
more effective tools to protect nature.
The penguin case has amply demonstrated
this need. Perhaps, with that cooperation,
Latin American citizens may become
able to preserve not only penguins, but
also the entire sphere of nature, which is
under severe pressure from the aggressive methods of development that
serve only to satisfy the North, while exhausting the South. In the end, was protecting the lives of the penguins in Patagonia a sufficient learning experience
for Argentina, or would it have been a
more instructive (though harsher) lesson
if Argentines had been compelled to supply the fashion market of the world with
beautiful and sophisticated gloves for
delicate ladies?

/NT 1 STUD ANIM PROB 4(3) 1983

Alternatives to
Animal Experimentation
Steven M. Niemi
Steven M. Niemi is a postdoctural associate in the Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA 02139. This paper is a winner of the Animal Welfare Science Essay
Competition, The Institute for the Study of the Animal Problems, 1981, submitted while Dr. Niemi was a
veterinary student in the College of Veterinary Medicine, Washington State University.

Alternatives to animal experimentation are highly touted today by animal welfare advocates. Their campaign for adoption of alternatives has caused much discussion and debate within and outside of the biomedical community. The purpose of
this paper was to examine the controversy and assess the more common alternatives,
including the bacterial mutagenicity assay or Ames test, cell culture, and mathematical models for toxicity prediction. Safety testing of chemicals is the most promising
of the fields for alternatives where laboratory animals are used, and incorporation of
alternatives with live-animal assays is increasing. However, due to limitations of alternatives in use currently, there is still considerable need for in vivo systems. The veterinarian is central to the question of alternatives, in terms of humane considerations as
well as the usefulness of animals in science. An effective role for the veterinarian is to
serve as educator and mediator between the scientist using laboratory animals and
the animal welfare proponent.

Zusammenfassung
Alternativen zu Tierversuchen stehen heute sehr in Gunst bei den FUrsprechern
des Tierschutzes. lhre Kampagne fUr die Akzeptierung von Alternativen gab Anlass
zu zahlreichen Diskussionen und Debatten innerhalb und asserhalb biomedizinischer Fachgruppen. Zweck dieses Artikels ist es, diese Kontroverse zu untersuchen
und den Wert der wichtigsten Alternativen festzulegen, unter Einbezug der
bakteriellen MutagenitatsprUfung oder des Ames Tests, der Zellkultur und
mathematischer Madelle fi.ir die Voraussage von Toxizitat. Die Sicherheitspri.ifung
von Chemikalien, bei der Versuchstiere verwendet werden, ist wahl das meistversprechende Anwendungsgebiet fi.ir Alternativen und der Einbezug von Alternativen in Proben von lebenden Tieren ist im Wachsen. Jedoch im. Hinblick auf die
begrenzte Zahl von heute in Venwendung stehenden Alternativen besteht fi.ir in vivo
Systeme noch eine bedeutende Nachfrage Der Veterinar stellt eine Zentralfigur in der
Frage der Alternativen dar, sowohl aus Grunden humaner Ri.ichsichtnahmen als
auch in Bezug auf die NUtzlichkeit von Tieren in der Wissenschaft. Der Veterinar
spielt insofern eine wichtige Rolle, da er als Erzieher und Mittelsmann zwischen
dem Wissenschaftler, der Versuchstiere verwendet, und dem Vertreter des
Tierschutzes steht.
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Introduction
Animals have been used by man for
at least several centuries to obtain knowledge. As that knowledge further revealed
the unity of Earth's life forms, animals
were used in increasing numbers in the
laboratory as surrogates for humans. Although the benefits of animal experimentation were sometimes not immediately
apparent, the laboratory animal has contributed greatly to the welfare of humans as well as other animals (Bustad et
a/., 1976; Migaki, 1981). Today, animals
are used in education, research diagnosis, testing compounds for efficacy and
safety, and production of biologics.
There are currently 40 to 90 million
laboratory animals in use in the United
States, 80 to 90 percent of which are
rodents (Institute for Laboratory Animal
Resources, 1980; Rowan, 1981 a).
Opposition to the use of animals
for obtaining knowledge is as old as animal research itself. Motives for opposing animal experimentation include belief in the absolute rights of animals,
humanitarian motives, scientific motives,
economic motives, and legal motives.
The moral and ethical arguments of antivivisection and animal welfare advocates
center around whether there are any legitimate grounds for inflicting any pain,
intentionally or otherwise, on animals
for intellectual gain. Other proponents
of animal welfare have adopted a more
moderate view (Fox, 1981; Rowan, 1981 b).
While recognizing the contributions
science has made to humanity through
animal experimentation, this faction is
concerned about wasteful, exceptionally cruel, or unnecessary use of laboratory animals, and their aim is to curtail
these abuses (Rowan, 1980a). The most
eloquent (and least offensive to the biomedical establishment) program for reducing "inhumanity" to laboratory animals was formulated by Russell and Burch
(1959). They presented a concept of the
"3 R's": Replacement of laboratory animals with suitable alternative methods,
242
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Refinement of research or test protocols
to lessen animal suffering, and Reduction in the number of animals used. This
creed has been adopted by both sides of
the laboratory animal welfare issue as a
worthwhile goal (Rowan, 1980b; Smyth,
1978).
Traditionally, the antivivisectionist
attitude has meant general opposition to
biomedical research. This is because there
were few adequate substitutes available
for the live animal which, historically,
was the conventional tool of science. But
recent advances in electronic and in vitro technology, coupled with a vast extension of our knowledge at the cellular
and subcellular levels of biology, have
provided substitutes for I aboratory animals in many instances. These advances
have been seized upon (ironically) by
many in the animal welfare community
as complete replacements for the laboratory animal. Therefore, any further use
of animals for science, in their minds, is
unnecessary. Moderate voices in the movement have also been encouraged by
these scientific achievements, and there
is increasing clamor for greater use of
these technologies in the place of animals. Scientific and economic motives
are also playing an increasing role in the
transition from animals to alternatives.
Scientific objections put forward
both by researchers and animal welfare
advocates include: (1) the variability
among mammalian species in anatomy,
physiology, and behavior; and (2) the
variability among animals of the same
species due to genetic and environmental factors, and thus the appl icabi I ity of
the results obtained to human health
(Rowan, 1981 a; Lang and Vessell, 1976).
Economic motives will be addressed later
in the paper. Unlike the situation in other
nations, there are no legal incentives for
adopting alternatives in the United States
(Smyth, 1978; Anon., 1981 a).
There is another reason for promoting alternatives- namely, the problem of
environmental pollution and its effect
/NT 1 STUD ANIM PROB 4(3] 1983
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on public health. Approximately 63,000
chemicals are in use today, with 1,000
new ones being added each year. It is
also estimated that 80 percent of all human cancer is of environmental origin
and that only 7,000 chemicals have been
tested (adequately or otherwise) for carcinogenicity (Rowan, 1981 a). One can
thus see the enormous backlog of safety
evaluation that needs to be addressed. It
has been calculated that with current in
vivo testing resources, only 500 additional
compounds could be tested each year.
In addition, animal assays for carcinogenicity and toxicity require an investment of over 800 animals, at least 3 years,
and $150,000 to $500,000 per compound
(Rowan, 1981 a; Mu u I eta/., 1976). To test
those compounds commonly exposed to
humans as well as compounds new to society would cost over 2 billion dollars
and require over 1.6 million animals, using
conventional assays (CSPCA, 1980). Therefore, there is a critical need for faster
and cheaper tests to detect carcinogens,
at least at ~he initial stages of evaluation. The pressure from these problems
will soon supercede the animal welfare
argument in hastening any transition to
alternative methods of testing.
The purpose of this paper is to discuss the current situation regarding the
alternatives controversy and examine
strategies used to encourage the adoption of alternative methods in science.
Some of the more common alternatives
will be mentioned, and comments will
be made on the role of the veterinarian
regarding this issue.
The concept of alternatives is best
defined in the context of the 3 R's
(Rowan, 1980b). Replacement is the most
obvious and most common goal for those
in the animal welfare field, but there are
notable examples of alternatives involving different approaches. One example
of Reduction is the pooling of resources
in nonhuman primate research as described
by Moor-jankowski eta/. (1980). In this
system, the animals serving as negative
/NT 1 STUD ANIM PROB 4(3} 1983
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controls or "sentinels" for infectious
agents were used as sources for biological materials by other investigators. An
example of Refinement is the alteration
of the mouse assay for tetanus antitoxin
in Great Britain. Formerly, a lethal end
point was required in mouse inoculation
tests for the positive controls. But since
1977, the British Pharmacopoeia has recommended a paralytic end point, in which
the mouse suffers only a temporary and
mild hind-limb paralysis and eventually
recovers completely (Rowan, 1981 a).
While adversaries agree on the attractiveness of the 3 R's, how quickly and by
what means they are achieved is a matter of great disagreement. The scientific
community has maintained that successful alternatives have arisen from within
science by intellectual insight and tedious
research, without the need for external
prodding. When deemed acceptable, these
alternatives have been quickly adopted
and, it is argued, this approach will continue to be just as fruitful and dependable in the future (Gowans, 197 4; Smyth,
1978; Grafton, 1981 ).
However, those concerned primarily with animal welfare are not satisfied
with the pace of alternatives research
and development and have sought other
routes to achieve their goals. These routes
include confrontation, collaboration, and
legislation. Each will be discussed in turn.

Confrontation
An example of confrontation on a
national scale is the recent campaign
against the Draize test. The Draize test
is the accepted eye irritancy test; it is required for all compounds intended for
human ocular or conjunctival use, or
where exposure to human eyes is likely.
The rabbit is the test subject, and the
compound to be evaluated is instilled in
the conjunctival sac of one eye, the
other eye serving as the negative control. Before 1982, standard protocols
called for the use of six to nine rabbits
per compound, but recent guidelines have
243
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reduced the number required. The eyes
are monitored for up to 3 weeks, and
any lesions or evidence of irritation that
develops is scored quantitatively (Interagency Regulatory Liaison Group, 1981).
Objections to the in vivo assay included the facts that: (1) too many rabbits were used repeatedly; (2) at higher
doses, some of the compounds were extremely irritating or even necrotizing;
and (3) no anesthesia was usually provide9
to the rabbits. The cosmetics industry
was a special target of the anti-Draize
campaign because the Draize test was
extensively employed in the manufacture of eye makeups, hair sprays, and
other similar products. Since there are
already many such products available to
consumers, Draize opponents felt that
subjecting more rabbits to discomfort
for the development of new beauty products was a needless consequence of human vanity (H arriton, 1981 ).
As a resu It of the anti-Draize campaign, the Revlon Company donated
$750,000 to Rockefeller University to
finance a 3-year program to develop an
alternative to the Draize test. Shortly
after Revlon's gift was made, the Cosmetics, Toiletry, and Fragrance Association
established a fund, eventually totaling
over 1 million dollars, to be managed by
the Johns Hopkins Center for Alternatives to Animal Testing (Anon., 1982a).
There are also scientific objections
to the Draize test (Simons, 1980). Rabbits are suspect in their ability to detect
moderate irritants, although they can be
used to distinguish between severe irritants and non-irritants. There is also uncertainty as to the similarity between
the human and rabbit eye with regard to
sensitivity to irritants. Although there
are no alternatives to the Draize test
currently available, some techniques are
being investigated. These include evaluating in vitro cytotoxicity in established
cell lines upon exposure to the irritant
(Simons, 1980), and measuring serotonin
release from irritated rat peritoneal ma244

crophages after in vitro exposure (McCormack, 1981 ).

Collaboration
The second strategy used by animal
welfare advocates is collaboration. Certainly this is more palatable to the scientific community and has been more favorably received. Animal welfare organizations have actively participated in recent scientific symposia on laboratory
animals and alternatives, e.g., the Animal Welfare Institute, the Canadian Society for the Prevention of Cruelty to Animals, and the Fund for the Replacement
of Animals in Medical Experiments, among
others (National Academy of Sciences,
1977; Rowan and Stratmann, 1980; CSPCA,
1980).
Another approach involving collaboration is the direct financing by animal
welfare organizations of scientific research on alternatives. Most of these
ventures have not been as fruitful as
hoped, but the mere fact that animal welfare groups are participating in this manner is important and should be encouraged. It indicates a reversal of values, in
that organizations that were previously
suspicious of science in general are now
turning to science for assistance. Even if
no breakthroughs are achieved, these sponsors will gain a better understanding of
the scientific method, the necessity and
value of controlled experimentation, and
perhaps an appreciation for the disadvantages as well as the advantages of alternatives in certain situations. One noteworthy contribution arising from private
support is the in vitro tumorigenicity test
developed by Petricciani and others and
sponsored by the American Fund for Alternatives to Animal Research (Noguchi
et a/., 1978).

Legislation
A third strategy employed by animal welfare groups is advocacy for legislation. Presently, there are three sets of
/NT
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federal regulations pertaining to the husbandry of laboratory animals: the United
States Department of Agriculture's Animal Welfare Act, the Food and Drug Administration's Good Laboratory Practices,
and the National Institutes of Health's
Guide for Grants and Contracts, which
includes animal care policies (Townes,
1980). None of these programs regulates
research per se but, rather, defines the
framework of laboratory animal use within which that research can be conducted.
There are several bills in the current
session of the United States congress
that pertain to the promotion of alternatives to laboratory animals, and all have
originated from or have the support of at
least some groups from the animal welfare lobby (Randall, 1981; Anon., 1981 b).
Advocates of these bills contend that
the current level of animal experimentation grossly exceeds the need for such
use. They argue that acceptable alternatives exist today and that adoption of
these alternatives is slowed by convention, bureaucratic inefficiency, and the
lack of "encouragement" for using alternatives (Broad, 1980). Thus, they believe
that some central agency or federal directive is needed to expedite the transition
to animal replacements.
Many biomedical administrators and
scientists oppose such legislation because
they feel it is unnecessary, cumbersome,
and duplicative. All of the replacements
for animals in use today were developed
in the laboratory in response to a greater
need for specificity and sensitivity. The
need still exists but, in their opinion, it
would be wrong to believe that by mandating the process and providing more
money the system would be any more
productive (Broad, 1980; Anon., 1982b).

How Do Alternatives Compare
with Animals?
The common alternatives used by
science as well as promoted by animal
welfare activists can be classified as follows: physicochemical techniques, micro/NT
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biological systems, in vitro eukaryotic
systems, in vivo eukaryotic systems, computers and mathematical models, and expanded clinical and epidemiological studies in humans.
Physicochemical techniques involve the use of radioactive isotopes,
gas-liquid chromatography, and mass
spectrometry. It has been argued that
these techniques do not substitute for
animals, but make results obtained with
animals more specific and provide more
information (Smyth, 1978). It is also suggested that rather than reduce the
number of animals used, physicochemical techniques may actually, in some instances, increase the need for more
animals, due to the new questions they
may pose to an investigator. However,
others have documented examples where
physicochemical techniques have replaced animals- as in vitamin A bioassays (Rowan, 1981 a).
This illustrates, on a small scale, the
problem of determining just how successful computer systems, in vitro systems,
and clinical studies can be as alternatives
to animals. Space is too limited here for
detailed analyses, and the reader is referred
to several books that have appeared on
the subject in recent years (Rowan and
Stratmann, 1980; Smyth, 1978; National
Academy of Sciences, 1977).
How do in vitro systems compare
with the laboratory animal in terms of
sensitivity or specificity? The most realistic comparison to be made is in the
safety testing sector, since the purpose
and end points involved here are agreed
upon by most. Research, on the other
hand, entails more personal choice and
therefore more varied endeavors which
do not always offer the same opportunities for transposition between animals
and alternatives. Most in vitro systems
for detecting carcinogencity in a compound exhibit 50 to 90 percent agreement with the in vivo results (Bridges,
1976; Ames and Hooper, 1978; Anon.,
1980a). One study in which one laboratory
245
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biological systems, in vitro eukaryotic
systems, in vivo eukaryotic systems, computers and mathematical models, and expanded clinical and epidemiological studies in humans.
Physicochemical techniques involve the use of radioactive isotopes,
gas-liquid chromatography, and mass
spectrometry. It has been argued that
these techniques do not substitute for
animals, but make results obtained with
animals more specific and provide more
information (Smyth, 1978). It is also suggested that rather than reduce the
number of animals used, physicochemical techniques may actually, in some instances, increase the need for more
animals, due to the new questions they
may pose to an investigator. However,
others have documented examples where
physicochemical techniques have replaced animals- as in vitamin A bioassays (Rowan, 1981 a).
This illustrates, on a small scale, the
problem of determining just how successful computer systems, in vitro systems,
and clinical studies can be as alternatives
to animals. Space is too limited here for
detailed analyses, and the reader is referred
to several books that have appeared on
the subject in recent years (Rowan and
Stratmann, 1980; Smyth, 1978; National
Academy of Sciences, 1977).
How do in vitro systems compare
with the laboratory animal in terms of
sensitivity or specificity? The most realistic comparison to be made is in the
safety testing sector, since the purpose
and end points involved here are agreed
upon by most. Research, on the other
hand, entails more personal choice and
therefore more varied endeavors which
do not always offer the same opportunities for transposition between animals
and alternatives. Most in vitro systems
for detecting carcinogencity in a compound exhibit 50 to 90 percent agreement with the in vivo results (Bridges,
1976; Ames and Hooper, 1978; Anon.,
1980a). One study in which one laboratory
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performed a comparative survey using
the same personnel and same equipment in the same time period (so as to
reduce as many external variables as
possible) is reported by Bridges (1976).
This analysis was performed for 120
chemicals and produced the following
resu Its, expressed as percent agreement
with animal or human data: bacterial
mutation with metabolic activation (Ames
test), 90 percent; cell transformation in
vitro, 83 percent; degranulation of endoplasmic reticulum, 72 percent. Certain
assays performed very well for certain
classes of compounds, but were quite inaccurate for others. The Ames test was
clearly the most accurate of those
tested; perhaps 9Q percent correlation
with in vivo results is the best to be expected, given the dissimilarity between the
in vivo state and that of bacteria or cells
in culture, as well as the fact that the animal assay is not foolproof either (Ames
and Hooper, 1978). To provide for increased efficiency and maximal accuracy, carcinogenicity and toxicity
testing will most likely evolve in the
near future to incorporate both in vivo
and in vitro systems (Weisburger and
Williams, 1981).

The Bottom Line
To summarize the controversy,
there are two points where enlightened
spokespersons for and against animal
use can agree: (1) animals will be required, if not desired, in the laboratory.
for some time to come, most notably in
research; and (2) no substitute for the entire live animal currently exists because
the in vivo state is too complex and too
poorly understood at this time. It should
be appreciated that the greatest promise
for alternatives lies in those disciplines
that focus on particular biological phenomena not requiring live animal subjects.
Much of biology has advanced to a level
of sophistication where the animal may
serve only as a source of biomaterials
for in vitro investigations, or where
246
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abiotic methods are preferred. An example of the former is the rapid adoption
of monoclonal antibody technology, replacing rabbits and other mammals as a
means of producing antisera (Kennett,
1981 ). But there remain fields of study
that depend, at least in part, on the I ive
animal and all of its intricate interplay
among physiologic systems. These fields
include experimental surgery and ethology.
Conversely, the points of disagreement center around (1) the current degree to which animals are used, given
that there are alternatives applicable to
specific biological processes that we already understand; and (2) the paucity of
support given to alternatives in general
(Rowan, 1981 b).
But a consistently major point of
debate is the quality of care that laboratory animals receive, as well as the attitudes of those who use them. In support of those who argue that progress is
too slow in providing better care for
laboratory animals, a national survey of
laboratory animal facilities noted that
fewer facilities than expected had become accredited by the American Association for Accreditation of Laboratory
Care in the last 10 years (I LAR, 1980).
Furthermore, laboratory animal veterinarians have complained of the reluctance of grant recipients or administrators to devote an adequate proportion
of their funds to housing and care of animals (Leeper, 1976). On the other hand,
the same national survey confidently
predicted continued growth of the veterinary labor force in laboratory animal
medicine (ILAR, 1980).

The Laboratory Animal
Veterinarian
What role should the laboratory
animal veterinarian play in the alternatives controversy? Or, should any role be
assumed at all? Since his or her position
is central to laboratory animal welfare,
the veterinarian will become involved
by force of circumstance if not by detNT
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sign. The responsibilities of the laboratory animal clinician have grown enormously iri the last decade, partly in response to a greater concern for animal
health and welfare from within and outside scientific confines. In addition to
managing the laboratory animal colony,
he or she may be expected to advise investigators on the appropriateness of
particular animals as models and on
which ones to use in specific experiments;
to instruct investigators on the proper
handling of animals; to assess protocols
involving animals; to implement and
monitor policies to comply with federal
regulations on animal care and housing
(Bradbury, 1980); and to justify the use
of animals in the laboratory. In this last
regard, the veterinarian's position has
become more politicized and the trend
will likely continue. In most instances,
the defense of animal experimentation
has been retrospective in scope, in that
historical examples of biomedical advances that were achieved with animals
are offered as evidence. It is then argued
that similar advances in the future must
also utilize animals (Migaki, 1981).
As more scientists turn to alternatives, for whatever reasons, and as more
scientists become sympathetic to the
animal welfare "cause," laboratory animal veterinarians will have to adopt new
viewpoints, of a prospective nature, to
be able to discuss intelligently the potential and limitations for both in vivo
and in vitro systems. In addition, they
will likely have to work in closer conjunction with animal welfare representatives
in performing their duties. This is already
being done in Canada on a national scale,
outside of any federal directive (Rowsell, 1980; Anon., 1980b). Involvement of
the animal welfare community in laboratory animal care and use is an important development, and it is necessary if
the two sides are to find common
ground or minimize further conflict and
misunderstanding. The actual day-today activities of biomedical research
/NT
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and testing are often poorly presented
to the public (Rowan and Stratmann,
1980). If the public is concerned with the
welfare of laboratory animals, their ignorance of what actually occurs in the
vivarium and laboratory can only harm
the image of biomedical science and further increase the public's suspicions.
This is especially true when their suspicions are confirmed, as occurred in the
recent Silver Spring animal cruelty case
(Kershner, 1982).
As a partial remedy to the information gap, some suggest publishing detailed
husbandry protocols in addition to experiments, so as to better inform the
reader (and public) on how the animals
were cared for and used in the research.
Others encourage more interaction between scientists and animal welfare advocates to accommodate the concerns
of both sectors of society; again, the laboratory animal clinician's role is pivotal.
Public relations and education may well
become a major duty of the laboratory
animal veterinarian in the near future
(Loew, 1981 ).

The Veterinarian tn Private
Practice
What of the private veterinary practitioners? They may also become involved
in the controversy surrounding alternatives through discussions with concerned
clients or in consultations with local
humane organizations. Some of the more
sensational animal welfare groups distribute literature containing photographs
of cute pets or mutilated carcasses of
companion animal species, and accuse
science of butchery. The client is often
the recipient of such literature and will
ask his or her veterinarian about the
charges. Similar articles in the communications media will also concern the
client, as will claims by animal welfare
advocates that this destruction of animal
life is unnecessary today since cell cultures and computers can substitute completely for the laboratory animal. Hope247

S. Niemi-Alternatives

:!

.!

performed a comparative survey using
the same personnel and same equipment in the same time period (so as to
reduce as many external variables as
possible) is reported by Bridges (1976).
This analysis was performed for 120
chemicals and produced the following
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1981 ). But there remain fields of study
that depend, at least in part, on the I ive
animal and all of its intricate interplay
among physiologic systems. These fields
include experimental surgery and ethology.
Conversely, the points of disagreement center around (1) the current degree to which animals are used, given
that there are alternatives applicable to
specific biological processes that we already understand; and (2) the paucity of
support given to alternatives in general
(Rowan, 1981 b).
But a consistently major point of
debate is the quality of care that laboratory animals receive, as well as the attitudes of those who use them. In support of those who argue that progress is
too slow in providing better care for
laboratory animals, a national survey of
laboratory animal facilities noted that
fewer facilities than expected had become accredited by the American Association for Accreditation of Laboratory
Care in the last 10 years (I LAR, 1980).
Furthermore, laboratory animal veterinarians have complained of the reluctance of grant recipients or administrators to devote an adequate proportion
of their funds to housing and care of animals (Leeper, 1976). On the other hand,
the same national survey confidently
predicted continued growth of the veterinary labor force in laboratory animal
medicine (ILAR, 1980).
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health and welfare from within and outside scientific confines. In addition to
managing the laboratory animal colony,
he or she may be expected to advise investigators on the appropriateness of
particular animals as models and on
which ones to use in specific experiments;
to instruct investigators on the proper
handling of animals; to assess protocols
involving animals; to implement and
monitor policies to comply with federal
regulations on animal care and housing
(Bradbury, 1980); and to justify the use
of animals in the laboratory. In this last
regard, the veterinarian's position has
become more politicized and the trend
will likely continue. In most instances,
the defense of animal experimentation
has been retrospective in scope, in that
historical examples of biomedical advances that were achieved with animals
are offered as evidence. It is then argued
that similar advances in the future must
also utilize animals (Migaki, 1981).
As more scientists turn to alternatives, for whatever reasons, and as more
scientists become sympathetic to the
animal welfare "cause," laboratory animal veterinarians will have to adopt new
viewpoints, of a prospective nature, to
be able to discuss intelligently the potential and limitations for both in vivo
and in vitro systems. In addition, they
will likely have to work in closer conjunction with animal welfare representatives
in performing their duties. This is already
being done in Canada on a national scale,
outside of any federal directive (Rowsell, 1980; Anon., 1980b). Involvement of
the animal welfare community in laboratory animal care and use is an important development, and it is necessary if
the two sides are to find common
ground or minimize further conflict and
misunderstanding. The actual day-today activities of biomedical research
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and testing are often poorly presented
to the public (Rowan and Stratmann,
1980). If the public is concerned with the
welfare of laboratory animals, their ignorance of what actually occurs in the
vivarium and laboratory can only harm
the image of biomedical science and further increase the public's suspicions.
This is especially true when their suspicions are confirmed, as occurred in the
recent Silver Spring animal cruelty case
(Kershner, 1982).
As a partial remedy to the information gap, some suggest publishing detailed
husbandry protocols in addition to experiments, so as to better inform the
reader (and public) on how the animals
were cared for and used in the research.
Others encourage more interaction between scientists and animal welfare advocates to accommodate the concerns
of both sectors of society; again, the laboratory animal clinician's role is pivotal.
Public relations and education may well
become a major duty of the laboratory
animal veterinarian in the near future
(Loew, 1981 ).

The Veterinarian tn Private
Practice
What of the private veterinary practitioners? They may also become involved
in the controversy surrounding alternatives through discussions with concerned
clients or in consultations with local
humane organizations. Some of the more
sensational animal welfare groups distribute literature containing photographs
of cute pets or mutilated carcasses of
companion animal species, and accuse
science of butchery. The client is often
the recipient of such literature and will
ask his or her veterinarian about the
charges. Similar articles in the communications media will also concern the
client, as will claims by animal welfare
advocates that this destruction of animal
life is unnecessary today since cell cultures and computers can substitute completely for the laboratory animal. Hope247
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--f.t:tlty;--the practitioner will se1ze the opportunity to perform a service for his
profession (and the biomedical industry
that supports it) by educating the client
or the humane society chapter in his
town on the complexities of the issue.

Conclusion
In many instances, animal experimentation has been or is being minimized; there are many more opportunities
for utilizing alternatives (in a// aspects of
the concept). However, in many cases,
animal research still proves to be the
best way to approach a problem. Suppression of the uti! ization of any resources, be they laboratory animals or
alternatives, imposes a serious limitation
on scientific progress for human welfare.
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